Iowa Code § 124B.2 — IA Code / Title IV / Chapter 124B / Section 124B.2
Reporting required.
Status: in_force

(1) A report to the board shall be submitted in accordance with this chapter by a manufacturer, retailer, or other person who sells, transfers, or otherwise furnishes to any person in this state any of the following substances:

(1) (a) Anthranilic acid, its esters, and its salts.

(1) (b) Benzyl cyanide.

(1) (c) Ethylamine and its salts.

(1) (d) Ergonovine and its salts.

(1) (e) Ergotamine and its salts.

(1) (f) 3,4 - methylenedioxyphenyl-2-propanone.

(1) (g) N-acetylanthranilic acid, its esters, and its salts.

(1) (h) Norpseudoephedrine, its salts, optical isomers, and salts of optical isomers.

(1) (i) Phenylacetic acid, its esters, and its salts.

(1) (j) Piperidine and its salts.

(1) (k) Methylamine and its salts.

(1) (l) Propionic anhydride.

(1) (m) Isosafrole.

(1) (n) Safrole.

(1) (o) Piperonal.

(1) (p) N-methylephedrine, its salts, optical isomers, and salts of optical isomers.

(1) (q) N-methylpseudoephedrine, its salts, optical isomers, and salts of optical isomers.

(1) (r) Hydriodic acid.

(1) (s) Benzaldehyde.

(1) (t) Nitroethane.

(1) (u) Gamma-Butyrolactone (also known as GBL; Dihydro-2(3H)-furanone; 1,2-Butanolide; 1,4-Butanolide; 4-Hydroxybutanoic acid lactone; or gamma-hydroxy-butyric acid lactone).

(1) (v) Red phosphorus.

(1) (w) White phosphorus (another name:yellow phosphorus).

(1) (x) Hypophosphorous acid and its salts (including ammonium hypophosphite, calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite).

(1) (y) Iodine in concentrations greater than 2.2 percent.

(1) (z) N-phenethyl-4-piperidone (NPP).

(1) (aa) Ergocristine and its salts.

(1) (ab) Alpha-phenylacetoacetonitrile and its salts, optical isomers, and salts of optical isomers. Other name: APAAN.

(1) (ac) N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide (benzylfentanyl) and its salts.

(1) (ad) N-phenylpiperidin-4-amine(4-anilinopiperidine; N-phenyl-4-piperidinamine; 4-AP), its amides, its carbamates, its halides, its salts, and any combination thereof, whenever the existence of such is possible.

(1) (ae) 3,4-MDP-2-P methyl glycidate (PMK glycidate) and its optical and geometric isomers.

(1) (af) 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid) and its salts, optical and geometric isomers, and salts of isomers.

(1) (ag) Alpha-phenylacetoacetamide (APAA) and its optical isomers.

(1) (ah) Methyl alpha-phenylacetoacetate and its optical isomers. Other names: MAPA; methyl 3-oxo-2-phenylbutanoate.

(1) (ai) 1-boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) and its salts.

(1) (aj) 4-piperidone (piperidin-4-one), its acetals, its amides, its carbamates, its salts, and salts of its acetals, its amides, and its carbamates, and any combination thereof, whenever the existence of such is possible.

(2) The board shall administer the regulatory provisions of this chapter and may, by rule adopted pursuant to chapter 17A, add a substance to or remove a substance from the list in subsection 1. In determining whether to add or remove a substance from the list, the board shall consider the following:

(2) (a) The likelihood that the substance may be used as a precursor in the illegal production of a controlled substance.

(2) (b) The availability of the substance.

(2) (c) The appropriateness of including the substance under this chapter or under chapter 124.

(2) (d) The extent and nature of legitimate uses for the substance.

(3) On or before November 1 of each year, the board shall inform the general assembly of any substances added, deleted, or changed in the list contained in this section and shall provide an explanation of any addition, deletion, or change.

90 Acts, ch 1251, §11C91, §204B.2C93, §124B.22000 Acts, ch 1140, §17, 18; 2002 Acts, ch 1108, §2, 3; 2003 Acts, ch 53, §10; 2008 Acts, ch 1010, §5; 2009 Acts, ch 36, §1; 2012 Acts, ch 1122, §6; 2018 Acts, ch 1138, §30, 31; 2021 Acts, ch 93, §35, 36, 38; 2022 Acts, ch 1049, §10, 11; 2023 Acts, ch 61, §5, 6; 2024 Acts, ch 1101, §8, 9; 2025 Acts, ch 10, §8, 10